2016
New Organ Allocation System for Combined Liver-Kidney Transplants and the Availability of Kidneys for Transplant to Patients with Stage 4–5 CKD
Asch WS, Bia MJ. New Organ Allocation System for Combined Liver-Kidney Transplants and the Availability of Kidneys for Transplant to Patients with Stage 4–5 CKD. Clinical Journal Of The American Society Of Nephrology 2016, 12: 848-852. PMID: 28028050, PMCID: PMC5477211, DOI: 10.2215/cjn.08480816.Commentaries, Editorials and LettersConceptsLiver-kidney transplantSimultaneous liver-kidney transplantOrgan allocationCombined liver-kidney transplantAvailability of kidneysMultiorgan transplant recipientsEquitable organ allocationMedical criteriaOrgan allocation systemLiver recipientsTransplant recipientsTransplant activityNephrology communityTransplantKidneyRecipientsStage 4Great controversyCKDPatientsAKICriteria
2014
Opting out: confidentiality and availability of an ‘alibi’ for potential living kidney donors in the USA
Thiessen C, Kim YA, Formica R, Bia M, Kulkarni S. Opting out: confidentiality and availability of an ‘alibi’ for potential living kidney donors in the USA. Journal Of Medical Ethics 2014, 41: 506. PMID: 25368413, DOI: 10.1136/medethics-2014-102184.Peer-Reviewed Original ResearchOncologic Issues and Kidney Transplantation: A Review of Frequency, Mortality, and Screening
Asch WS, Bia MJ. Oncologic Issues and Kidney Transplantation: A Review of Frequency, Mortality, and Screening. Advances In Kidney Disease And Health 2014, 21: 106-113. PMID: 24359993, DOI: 10.1053/j.ackd.2013.07.003.BooksMeSH KeywordsAnus NeoplasmsBreast NeoplasmsCarcinoma, Renal CellColorectal NeoplasmsEarly Detection of CancerFemaleHumansImmunocompromised HostImmunosuppressive AgentsKidney Failure, ChronicKidney NeoplasmsKidney TransplantationLymphoproliferative DisordersNeoplasmsSkin NeoplasmsUterine Cervical NeoplasmsConceptsStandard incidence ratioKidney transplantationKidney transplant recipientsDevelopment of malignancyReview of frequencyTransplant recipientsIncidence ratiosCommon malignancyTreatment recommendationsTumor surveillanceOncologic issuesGeneral populationTumor growthMalignancyOncogenic virusesCurrent preventionTransplantationRiskEarly ageImmunosuppressantsReviewCancerMortalityRecipientsPrevention
2008
Management of Cardiovascular Disease in Renal Transplant Recipients
Shirali AC, Bia MJ. Management of Cardiovascular Disease in Renal Transplant Recipients. Clinical Journal Of The American Society Of Nephrology 2008, 3: 491-504. PMID: 18287250, PMCID: PMC6631091, DOI: 10.2215/cjn.05081107.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsRenal transplant recipientsTransplant recipientsRisk factorsCardiovascular diseaseKidney Disease Outcomes Quality InitiativeCardiovascular risk factorsHigher cardiovascular mortalityMajor risk factorBest available studiesCause of deathHealth care professionalsAllograft survivalGraft lossCardiovascular eventsLifestyle modificationCardiovascular mortalityImmunosuppressive agentsDrug therapyClinical acumenGeneral populationCare professionalsMajor causeDiseaseRecipientsAvailable studies